Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

APOA2 Protein (AA 19-100) (His tag)

APOA2 Origin: Human Host: Escherichia coli (E. coli) Recombinant >90 % as determined by SDS-PAGE.
Catalog No. ABIN6809938
  • Target See all APOA2 Proteins
    APOA2 (Apolipoprotein A-II (APOA2))
    Protein Type
    Recombinant
    Protein Characteristics
    AA 19-100
    Origin
    • 9
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Source
    • 8
    • 6
    • 3
    • 2
    • 1
    • 1
    Escherichia coli (E. coli)
    Purification tag / Conjugate
    This APOA2 protein is labelled with His tag.
    Sequence
    AA 19-100
    Purity
    >90 % as determined by SDS-PAGE.
    Endotoxin Level
    Less than 1.0 EU per μg by the LAL method.
    Top Product
    Discover our top product APOA2 Protein
  • Restrictions
    For Research Use only
  • Format
    Lyophilized
    Buffer
    PBS, pH 7.4
    Handling Advice
    Please avoid repeated freeze-thaw cycles.
    Storage
    -20 °C
  • Target
    APOA2 (Apolipoprotein A-II (APOA2))
    Alternative Name
    Apolipoprotein A-II (APOA2 Products)
    Synonyms
    Apo-AII Protein, ApoA-II Protein, apoAII Protein, Alp-2 Protein, ApoAII Protein, Apoa-2 Protein, Hdl-1 Protein, APOAII Protein, apoa2 Protein, apoA-II Protein, cb1032 Protein, wu:fb57h11 Protein, zgc:193613 Protein, apolipoprotein A2 Protein, apolipoprotein A-II Protein, APOA2 Protein, Apoa2 Protein, apoa2 Protein
    Background
    Apolipoprotein A-II(APO-A2) stabilize HDL (high density lipoprotein) structure by its association with lipids, and affect the HDL metabolism. It is produced by the liver and is involved in cholesteryl ester formation and cholesterol transport from tissues to the liver. Recent studies have established the interaction between APOA2 -256T>C polymorphism and dietary saturated fatty acids intake in relation to obesity on healthy individuals. Significant interaction between APOA2-saturated fatty acids intake and body mass index (BMI). The result of this study confirmed the interaction between APOA2 -256T>C polymorphism and SFAs intake with BMI in type 2 diabetic patients.
    Molecular Weight
    11.3 kDa
    NCBI Accession
    NP_001634
    Pathways
    Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Negative Regulation of Transporter Activity, Lipid Metabolism
You are here:
Support